Inogen/$INGN
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Inogen
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
Ticker
$INGN
Sector
Primary listing
Employees
753
Headquarters
Website
Inogen Metrics
BasicAdvanced
$172m
-
-$0.92
1.65
-
Price and volume
Market cap
$172m
Beta
1.65
52-week high
$9.13
52-week low
$5.34
Average daily volume
385k
Financial strength
Current ratio
3.103
Quick ratio
2.474
Long term debt to equity
7.35
Total debt to equity
9.259
Profitability
EBITDA (TTM)
-8.812
Gross margin (TTM)
44.31%
Net profit margin (TTM)
-7.08%
Operating margin (TTM)
-8.56%
Effective tax rate (TTM)
2.77%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
-6.33%
Return on equity (TTM)
-13.07%
Valuation
Price to revenue (TTM)
0.492
Price to book
0.95
Price to tangible book (TTM)
1.21
Price to free cash flow (TTM)
-16.889
Free cash flow yield (TTM)
-5.92%
Free cash flow per share (TTM)
-0.377
Growth
Revenue change (TTM)
3.39%
Earnings per share change (TTM)
-20.31%
3-year revenue growth (CAGR)
-1.61%
10-year revenue growth (CAGR)
7.65%
3-year earnings per share growth (CAGR)
-38.42%
10-year earnings per share growth (CAGR)
4.35%
What the Analysts think about Inogen
Analyst ratings (Buy, Hold, Sell) for Inogen stock.
Inogen Financial Performance
Revenues and expenses
Inogen Earnings Performance
Company profitability
Inogen News
AllArticlesVideos
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Business Wire·2 months ago
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
Business Wire·2 months ago
Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs